Biosimulation Market Outlook 2025-2029: Key Trends Include Digital R&D Strategies, Biosimulation for Biomarker Identification, Digital Biomarkers and Endpoints & Advancements in Computational Biology
24. Januar 2025 04:04 ET
|
Research and Markets
Dublin, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The "Biosimulation Market Report 2025" has been added to ResearchAndMarkets.com's offering.The biosimulation market size is forecast to see rapid growth in...
In Vivo CRO Market Projected to Reach USD 7.96 Billion by 2030 with Substantial Growth Across Regions and Segments
14. Januar 2025 10:49 ET
|
Research and Markets
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "In Vivo CRO Market Size, Share & Trends Analysis Report By Model Type, By Modality, By Indication, By GLP Type, By Region, And Segment Forecasts,...
Provectus Biopharmaceuticals Announces Seed Financing for VisiRose, Provectus’s Spinoff Company for Rose Bengal-Based Eye Drugs
14. Januar 2025 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, Tenn., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced a $3 million seed financing round for VisiRose,...
Carterra Ships Its First Ultra Biosensor Platform and Finishes 2024 with Double-digit Growth and Record Revenues
07. Januar 2025 08:00 ET
|
Carterra
Carterra’s latest instrument enables high-throughput small and large-molecule characterization in traditional and AI-driven workflowsSALT LAKE CITY, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Carterra Inc.,...
CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 RA for the Treatment of Obesity and Diabetes
23. Dezember 2024 08:01 ET
|
Corxel Pharmaceuticals
CORXEL expands its cardiometabolic pipeline into obesity and diabetes.
Invea Therapeutics Strengthens Leadership with Appointment of Dr. Stephen Doberstein, Veteran Biotech Executive, to Its Board of Directors
12. Dezember 2024 10:05 ET
|
Invea Therapeutics
GUILFORD, Conn., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Invea Therapeutics, Inc. (Invea), a leading biotechnology company developing an artificial intelligence (AI), GenAI, and machine learning (ML)...
Small Molecule API Business Industry Research Report 2024: Global Market to Grow by Over $75 Billion to 2030 - Increasing Focus on Targeted Small Molecule Therapies Drives Adoption
05. Dezember 2024 04:01 ET
|
Research and Markets
Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Small Molecule API - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Small Molecule...
Analytical Methods Validation for FDA Compliance Drugs and Biologics: From Lab to Lab - Learn Crucial Techniques for Transferring Analytical Procedures (ONLINE EVENT: December 16-18, 2024/ON-DEMAND)
04. Dezember 2024 04:58 ET
|
Research and Markets
Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The "Analytical Methods Validation for FDA Compliance Drugs and Biologics" training has been added to ResearchAndMarkets.com's offering. Dependable...
Pharmaceutical CRO Market Report 2025-2030, Featuring Parexel, ICON, Laboratory Corporation of America, Thermo Fisher Scientific, Medpace, IQVIA, WuXi AppTec and Veeda Clinical Research
03. Dezember 2024 05:20 ET
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical CRO Market Size, Share & Trends Analysis Report by Type (Drug Discovery, Pre-Clinical, Clinical), Molecule Type (Small Molecules,...
Antibody-Drug Conjugates (ADC) Technology Research and Global Markets Report 2024-2025 & 2029 with Profiles of Leading Players - F. Hoffmann-La Roche., Daiichi Sankyo, Pfizer, and Gilead Sciences
04. November 2024 07:00 ET
|
Research and Markets
Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Antibody-Drug Conjugates: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global sales of ADCs on...